Introduction Medications for opioid use disorder (MOUD) are evidence-based treatments, yet
can be controversial among some populations. This study provides a systematic review of …

Abstract The United States opioid epidemic is a nationwide public health crisis. Initially
driven by increased consumption and availability of pharmaceutical opioids, an increasing …

On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for
Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the …

Policy Points This article reconceptualizes our understanding of the opioid epidemic and
proposes six strategies that address the epidemic's social roots. In order to successfully …

Objectives To characterize primary care physicians'(PCPs) attitudes and beliefs about
people with opioid use disorder (OUD) and to understand the association between PCPs' …

Importance Racial and ethnic disparities persist across key health and substance use
treatment outcomes for mothers and infants. The use of medications, such as methadone or …

Importance Since 1999, the United States has experienced increases in morbidity and
mortality associated with nonmedical use of prescription opioids. Objective To assess …

At least 2.3 million people in the US have an opioid use disorder, less than 40% of whom
receive evidence-based treatment. Buprenorphine used as part of medication-assisted …

The prevalence of opioid use and misuse has provoked a staggering number of deaths over
the past two and a half decades. Much attention has focused on individual risks according to …

The toll of untreated opioid use disorder is tremendous. In 2015, 33,091 Americans died
from a drug overdose involving an opioid. In just one year, the death rate from heroin …